|
?:authorAffiliation
|
-
[\'Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, REPROGRAM Immunity Sub-committee†.\', \'Department of Neurology & Neurophysiology, Liverpool Hospital and South Western Sydney Local Health District, Sydney, NSW, Australia.\', \'Neurovascular Imaging Laboratory & NSW Brain Clot Bank, Ingham Institute for Applied Medical Research, The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia.\', \'The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia.\', \'Polish Mother\'s Memorial Hospital Research Institute, Lodz, Poland.\', \'Cardiovascular Research Centre, University of Zielona Góra, Zielona Gora, Poland.\', \'Department of Hypertension, Medical University of Lodz, Lodz, Poland.\', \'Department of Rheumatology, University Health Network and The University of Toronto, Toronto, ON, Canada.\', \'Department of Neurology, University of Regensburg, Regensburg, Germany.\', \'Department of Neurology, Ben Taub General Hospital and Alzheimer\'s Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX, United States.\', \'World Health Organisation, Country Office for India, NPSP, Madurai, India.\', \'Department of Neuromicrobiology, National Institute of Mental Health and Neurosciences, Bengaluru, India.\', \'Department of Pediatric and Congenital Cardiology, Blalock-Taussig-Thomas Heart Center, John Hopkins Hospital, Baltimore, MD, United States.\', \'Johns Hopkins Bloomberg School of Public Health, School of Medicine, John Hopkins University, Baltimore, MD, United States.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}